Highlights: Biomarkers such as ACE and troponins are crucial for diagnosing cardiac sarcoidosis and myocarditis
Vous n'êtes pas connecté
Innovative research on Cell-free DNA (cfDNA) and other novel biomarkers for improved cardiac sarcoidosis and heart health outcomes.
Highlights: Biomarkers such as ACE and troponins are crucial for diagnosing cardiac sarcoidosis and myocarditis
Press Release October 24, 2024 On September 26, the Weeneebayko Area Health Authority (WAHA) and the University Health Network’s (UHN)...
Exploring heart and kidney health benefits of anti-diabetic treatment canagliflozin in older adults, focusing on improved outcomes and safety...
Competitive: Parexel: Parexel Early Phase Clinical Unit supports the development of innovative new medicines which are vital for public health,...
Competitive: Parexel: Parexel Early Phase Clinical Unit supports the development of innovative new medicines which are vital for public health,...
WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other...
Last week I saw a somewhat shabbily dressed man in the pharmacy trying to get a Covid booster. They told him it would cost $130. (It was the Moderna...
Research links traditional male gender norms with lower cardiovascular disease risk detection and treatment, impacting health outcomes.
The lifetime risk of an unexpected and sudden death from a cardiovascular cause in the absence of pre-existing heart disease-;known as sudden cardiac...